Glenmark Life Sciences informs about disclosure

22 Mar 2024 Evaluate
Glenmark Life Sciences has informed that the Company has submitted today March 22, 2024 an application for the reclassification of Glenmark Pharmaceuticals and Glenn Saldanha from ‘promoter and promoter group’ to ‘public shareholders’ to National Stock Exchange of India and BSE for their approval to approve such reclassification.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

907.15 1.75 (0.19%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×